Incannex Healthcare (IXHL) Non-Current Debt (2024)
Incannex Healthcare's (IXHL) quarterly Non-Current Debt came in at $2.4 million in Q4 2024.
Powered by 
Analysis
Incannex Healthcare (IXHL) Non-Current Debt (2024) Analysis & Trends
Incannex Healthcare has disclosed Non-Current Debt across 1 years of filings, most recently posting $2.4 million for Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 17.02 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | - |